Page 249 - Haematologica Vol. 107 - September 2022

LETTER TO THE EDITOR
thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet. 2000;67(6):1452-1459.
5. Soria JM, Morange PE, Vila J, et al. Multilocus genetic risk scores for venous thromboembolism risk assessment. J Am Heart Assoc. 2014;3(5):1-10.
6. McInnes G, Daneshjou R, Katsonis P, et al. Predicting venous thromboembolism risk from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges. Hum Mutat. 2019;40(9):1314-1320.
7. Salas E, Farm M, Pich S, et al. Predictive ability of a clinical- genetic risk score for venous thromboembolism in northern and southern european populations. TH Open. 2021;5(3):e303-e311.
8. Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859-1865.
9. Choi JJ, Wehmeyer GT, Li HA, et al. D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19. Thromb Res. 2020;196:318-321.
10. Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF. Youden
Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J. 2008;50(3):419-430.
11. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-845.
12. Dujardin RWG, Hilderink BN, Haksteen WE, et al. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients. Thromb Res. 2020;196:308-312.
13. Lindström S, Wang L, Smith EN, et al. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. Blood. 2019;134(19):1645-1657.
14. Hoiland RL, Fergusson NA, Mitra AR, et al. The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19. Blood Adv. 2020;4(20):4981-4989.
15. Pasha AK, McBane RD, Chaudhary R, et al. Timing of venous thromboembolism diagnosis in hospitalized and non- hospitalized patients with COVID-19. Thromb Res. 2021;207:150-157.
Haematologica | 107 September 2022
2248